Jackson Hole Capital Partners, LLC Abb Vie Inc. Transaction History

Jackson Hole Capital Partners, LLC

$490 Million
Q1 2025

A detailed history of Jackson Hole Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jackson Hole Capital Partners, LLC holds 35,511 shares of ABBV stock, worth $6.47 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares

35,511

Previous 35,947 1.21%

Holding current value

$6.47 Million

Previous $6.39 Million 16.49%

% of portfolio

1.52%

Previous 1.33%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$169.2 - $216.66 $73,771 - $94,463	-436 Reduced 1.21%	35,511 $7.44 Million
Q4 2024 Feb 07, 2025	BUY	$164.99 - $203.87 $296,487 - $366,354	1,797 Added 5.26%	35,947 $6.39 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $292,553 - $341,636	1,890 Added 5.86%	34,150 $5.86 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $299,183 - $340,891	-1,872 Reduced 5.48%	32,260 $5.87 Million
Q4 2023 Feb 02, 2024	BUY	$137.6 - $154.97 $240,662 - $271,042	1,749 Added 5.4%	34,132 $5.29 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $134,257 - $155,423	-1,005 Reduced 3.01%	32,383 $4.83 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $40,283 - $50,129	304 Added 0.92%	33,388 $4.5 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $92,695 - $106,752	-641 Reduced 1.9%	33,084 $5.27 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $38,035 - $45,614	-275 Reduced 0.81%	33,725 $5.45 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $78,781 - $90,356	587 Added 1.76%	34,000 $4.56 Million
Q2 2022 Jul 27, 2022	BUY	$137.62 - $174.96 $12,385 - $15,746	90 Added 0.27%	33,413 $5.12 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $34,578 - $42,902	-262 Reduced 0.78%	33,323 $5.4 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $212,066 - $268,325	1,974 Added 6.24%	33,585 $4.55 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $508,060 - $576,724	4,775 Added 17.79%	31,611 $3.41 Million
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $451,456 - $502,948	4,291 Added 19.03%	26,836 $3.02 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $380,351 - $418,721	3,718 Added 19.75%	22,545 $2.44 Million
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $62,299 - $84,110	774 Added 4.29%	18,827 $2.02 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $36,855 - $43,256	429 Added 2.43%	18,053 $1.58 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $37,638 - $50,366	513 Added 3.0%	17,624 $1.73 Million
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $127,194 - $192,841	1,972 Added 13.03%	17,111 $1.3 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $346,893 - $417,065	5,508 Added 57.19%	15,139 $1.15 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $191,909 - $245,305	2,921 Added 43.53%	9,631 $700,000
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $48,058 - $56,562	623 Added 10.23%	6,710 $541,000
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $473,872 - $584,412	6,087 New	6,087 $561,000

Others Institutions Holding ABBV

# of Institutions

4,272

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $322B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Hole Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Hole Capital Partners, LLC with notifications on news.

Account

Jackson Hole Capital Partners, LLC Abb Vie Inc. Transaction History